Aligos Therapeutics (ALGS) Return on Equity [ROE] (2020 - 2026)
Aligos Therapeutics (ALGS) posted Return on Equity [ROE] of -238.60% for Q2 2026, down 170.64 percentage points from -67.96% a year earlier and down 26.91 percentage points from the prior quarter.
Aligos Therapeutics (ALGS) Return on Equity [ROE] (2020 - 2026) Analysis & Trends
For FY2025, Aligos Therapeutics' Return on Equity [ROE] came in at -196.92%, up 218.92 percentage points from FY2024.
- Annual Return on Equity [ROE] shows a five-year change of -56.99 percentage points (FY2020 to FY2025).
- In prior years, Aligos Therapeutics' Return on Equity [ROE] was -415.84% in FY2024 (-326.36 pp), -89.48% in FY2023 (-22.92 pp), -66.55% in FY2022 (-3.14 pp) and -63.41% in FY2021 (+76.51 pp).
- The Q2 2026 figure stands as the lowest quarterly Return on Equity [ROE] since Q4 2024.
- On a year-over-year basis, Return on Equity [ROE] increased in five of the last eight quarters, with an average year-over-year change of -10.93 percentage points.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q4 2025, with a gain of 1203.76 percentage points; the weakest was Q4 2024, with a drop of 1122.98 percentage points.
- According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -211.69% (Q1 2026), -38.59% (Q4 2025) and -99.55% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | - |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 4.97% |
| 10 | Aligos Therapeutics | 52.83 Mn | -275.57 Mn | - | -238.60% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -238.60% |
| Mar 31, 2026 | -211.69% |
| Dec 31, 2025 | -38.59% |
| Sep 30, 2025 | -99.55% |
| Jun 30, 2025 | -67.96% |
| Mar 31, 2025 | -121.78% |
| Dec 31, 2024 | -1,242.35% |
| Sep 30, 2024 | -131.18% |
| Jun 30, 2024 | -119.24% |
| Mar 31, 2024 | -131.14% |
| Dec 31, 2023 | -119.37% |
| Sep 30, 2023 | -131.25% |
| Jun 30, 2023 | -106.56% |
| Mar 31, 2023 | -88.40% |
| Dec 31, 2022 | -85.03% |
| Sep 30, 2022 | -86.39% |
| Jun 30, 2022 | -87.20% |
| Mar 31, 2022 | -80.73% |
| Dec 31, 2021 | -63.89% |
| Sep 30, 2021 | -64.80% |
Aligos Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ALGS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ALGS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ALGS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();